FIELD: medicine, pharmacy. SUBSTANCE: ointment has propolis and base containing polyethylene oxide of molecular masses 400 and 1500 Da and nipagin and nipazol as preserving agents at the following ratio of components, wt. -%: propolis 10.69-11.81; polyethylene oxide of molecular mass 400 Da 60.57-66.93; nipagin 0.142-0.158; nipazol 0.19-0.21, and polyethylene oxide of molecular mass 1500 Da - the rest. Ointment can be used as an anti-inflammatory and wound-healing agent. EFFECT: decreased sickliness, accelerated epithelization of wound.
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION "OFLOMELID" FOR EXTERNAL APPLICATION IN PYOINFLAMMATORY DISEASE TREATMENT | 2007 |
|
RU2349302C1 |
RECTAL SUPPOSITORIUM "APROKSID" | 1998 |
|
RU2137468C1 |
OINTMENT FOR TREATMENT OF THROMBOPHLEBITIS | 1997 |
|
RU2107492C1 |
COMPOSITION FOR TREATMENT OF SKIN VIRAL DISEASE | 1996 |
|
RU2105545C1 |
MEDICINAL AGENT SHOWING REGENERATING AND WOUND-HEALING ACTION | 2000 |
|
RU2191574C2 |
DRUG FOR TREATMENT OF PATIENT WITH PROCTOLOGICAL DISEASES | 1998 |
|
RU2151592C1 |
SALICYLIC OINTMENT | 1995 |
|
RU2112506C1 |
METHOD OF PHOTOSENSIBILIZING AGENT PREPARING | 1993 |
|
RU2072861C1 |
PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL APPLICATION FOR INCREASE OF DRUG ACTIVITY AND DECREASE OF SIDE EFFECTS | 2010 |
|
RU2469706C2 |
AGENT FOR TREATMENT OF SKIN ACUTE INFLAMMATORY DISEASES | 1996 |
|
RU2105546C1 |
Authors
Dates
1999-08-27—Published
1997-07-29—Filed